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Adipogenesis is orchestrated by a highly ordered network of transcription factors including peroxisome-
proliferator activated receptor-gamma (PPARg) and CCAAT-enhancer binding protein (C/EBP) family
proteins. High mobility group protein AT-hook 2 (HMGA2), an architectural transcription factor, has been
reported to play an essential role in preadipocyte proliferation, and its overexpression has been impli-
cated in obesity in mice and humans. However, the direct role of HMGA2 in regulating the gene
expression program during adipogenesis is not known. Here, we demonstrate that HMGA2 is required for
C/EBPb-mediated expression of PPARg, and thus promotes adipogenic differentiation. We observed a
transient but marked increase of Hmga2 transcript at an early phase of differentiation of mouse 3T3-L1
preadipocytes. Importantly, Hmga2 knockdown greatly impaired adipocyte formation, while its over-
expression promoted the formation of mature adipocytes. We found that HMGA2 colocalized with C/
EBPb in the nucleus and was required for the recruitment of C/EBPb to its binding element at the Pparg2
promoter. Accordingly, HMGA2 and C/EBPb cooperatively enhanced the Pparg2 promoter activity. Our
results indicate that HMGA2 is an essential constituent of the adipogenic transcription factor network,
and thus its function may be affected during the course of obesity.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cellular differentiation is a highly ordered process, in which
stepwise expression and/or activation of transcription factors (TFs)
orchestrate the timely expression of a select set of genes [1e4].
During adipogenesis, preadipocytes undergo cell-cycle arrest fol-
lowed by the reconstitution of a gene expression program, leading
to the formation of lipid-accumulating mature adipocytes [5e7].
Upon adipogenic induction, key TFs including CCAAT-enhancer
binding protein (C/EBP) family factors sequentially operate tong Provincial Key Laboratory
olecular Biology, School of
ll Biology, Institute of Molec-
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Inc. This is an open access article uactivate the master adipogenic factor, peroxisome-proliferator
activated receptor-gamma (PPARg) [3]. Because the total adipo-
cyte number has been intimately linked to obesity in humans, it is
crucial to understand the precise mechanism of how preadipocytes
cease proliferation and initiate the adipogenic program.
High mobility group protein AT-hook 2 (HMGA2) belongs to the
non-histone chromosomal high mobility group (HMG) protein
family and functions as an architectural transcriptional factor by
recognizing AT-rich sequences in the minor groove of DNA and
enhancing gene transcription [8e10]. HMGA2 expression is absent
or very low in adult tissues, while it is highly expressed in embryos
and mesenchymal stem cells, implying that HMGA2 functions at an
early developmental stage [9]. A previous study demonstrated that
transgenic expression of Hmga2 in mice caused a giant phenotype
and hyperplasia of white adipose tissue (WAT) [11e13]. However,
Hmga2-deﬁcient mice exhibited a pygmy phenotype with drasti-
cally reduced fat tissue and resisted against diet-induced obesity
[14,15]. Importantly, a recent study reported signiﬁcantly elevated
levels of HMGA2 in human WAT of individuals with obesity and/ornder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
A list of primers used in current study.
qRT-PCR primers
36b4 S 50-CAACCCAGCTCTGGAGAAAC-30
36b4 AS 50-CCAACAGCATATCCCGAATC-30
b-actin S 50-CCAACCGTGAAAAGATGACC-30
b-actin AS 50-CCAGAGGCATACAGGGACAG-30
Adipone S 50-GGAACTTGTGCAGGTTGGAT-30
Adipone AS 50-TCTCCAGGAGTGCCATCTCT-30
C/EBPb S 50-ACAAGGCCAAGATGCGCAAC-30
C/EBPb AS 50-TTCCGCAGGGTGCTGAGCT-30
Cd36 S 50-CCATTGGTGATGAAAAAGCA-30
Cd36 AS 50-ATCACCACTCCAATCCCAAG-30
Fabp4 S 50-CATCAGCGTAAATGGGGATT-30
Fabp4 AS 50-GTCGTCTGCGGTGATTTCAT-30
Hmga2 S 50-CATCAGCCCAGGGACAAC-30
Hmga2 AS 50-GAGAGGGCTCACAGGTTGG-30
Pparg2 S 50-TGCAGGAGCAGAGCAAAGAG-30
Pparg2 AS 50-CGGCTTCTACGGATCGAAAC-30
ChIP primers
Pparg2-58kbS 50-GCATTTCAGAAGATTGGGTTTCA-30
Pparg2-58kb AS 50-CCAACTAAGGCATGACACTGAG-30
Pparg2-556 S 50-TTACCTGTGTGGGTAACAAAATC-30
Pparg2-468 AS 50-TGAAACTCCTAATCACACATCTG-30
Pparg2-1756 S 50-TGAACAGCAGTTGGGACTAGC-30
Pparg2-1892 AS 50-TGATAAACCAGATGACCATAAAAG-30
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involvement of HMGA2 in adipose tissue development and obesity.
A previous study demonstrated that HMGA2 promotes cell-
cycle progression by relieving retinoblastoma protein-mediated
repression of E2F1 activity [17]. Thus, a plausible cause of adipose
tissue atrophy in Hmga2 knockout mice is impaired cell prolifera-
tion, which results in the reduction of the number of preadipocytes
and consequent adipocytes. However, the precise function of
HMGA2 during the adipogenic process is still poorly understood.
Here, we report that a pulsatile expression of HMGA2 at the early
phase of adipogenesis drives C/EBPb-mediated induction of PPARg
and thus promotes differentiation. Our study suggests that HMGA2
plays an essential role in the transition of proliferative pre-
adipocytes to differentiating adipocytes, which may be a key event
during acquisition of the obese phenotype.
2. Materials and methods
2.1. Cell culture
Mouse 3T3-L1 cells were cultured in high glucose (4.5 g/L)
DMEM supplementedwith 10% heat-inactivated fetal bovine serum
and penicillin/streptomycin. Adipogenic differentiation of 3T3-L1
preadipocytes was performed as previously described [18]. Brieﬂy,
cells were maintained for 3 days post-conﬂuence and the medium
was changed to DMEM containing 0.5 mM 3-isobutyl-1-
methylxanthine (SigmaeAldrich), 1.0 mM dexamethasone (Sigma-
eAldrich), and 5.0 mg/mL bovine insulin (SigmaeAldrich) for 2
days. Cells were then cultured in a growth medium for an addi-
tional 3e8 days before collection. Isolation and culture of stromal
vascular fractions (SVFs) from inguinal WAT of C57BL/6 mice were
performed as previously described [18]. Lipid accumulation was
evaluated by oil red O staining, and the stained lipid droplets were
visualized by light microscopy and photographed. Animal experi-
ments were conducted in accordance with the guidelines of the
Animal Care and Use Committee of Kumamoto University.
2.2. Quantitative reverse transcription-polymerase chain reaction
(qRT-PCR)
Total RNAs were extracted by TRIZOL (Qiagen). RNAs were
reverse transcribed with the Transcriptor First Strand cDNA Syn-
thesis Kit (Roche). For quantiﬁcation, real-time PCR analysis was
performed using LightCycler 480 SYBR Green I Master on a Light-
Cycler 480 II (Roche) or ABI7500 Fast (Life Technologies). The
relative fold changes were quantiﬁed using the comparative
threshold cycle method, and b-actin was used as a control. Primers
are listed in Table 1.
2.3. Western blotting
Total proteins were extracted and separated by SDS-PAGE as
previously described [19]. Proteins were detected using antibodies
against HMGA2 (#5269, Cell Signaling), PPARg (sc-7273, Santa Cruz
Biotechnology), C/EBPb (sc-150, Santa Cruz Biotechnology), FABP4
(sc-18661, Santa Cruz Biotechnology), histone H3 (ab1791, Abcam),
b-actin (A1978, SigmaeAldrich), and FLAG (F3165, SigmaeAldrich).
2.4. Plasmid and transfection
To prepare the HMGA2 expression construct, human HMGA2
cDNA was cloned into the pcDNA3.1-FLAG vector (pcDNA3-FLAG-
HMGA2). We also ligated HMGA2 cDNA into the pCAG IRES-Puro
vector to generate the GFP-HMGA2 fusion construct (pCAG-GFP-
HMGA2), as described in our previous study [20]. Human C/EBPbcDNA was cloned into the pcDNA3.1 vector (pcDNA3-C/EBPb). DNA
fragments harboring C/EBPb and Pparg2 gene promoters were
synthesized in vitro at Shanghai Novobio Biotechnology (Shanghai,
China). Pparg2 promoter region containing the C/EBPb binding sites
from 363-bp to þ17-bp (from the transcription start site) was
cloned for analysis [21]. Newly synthesized sequences of Pparg2
promoter region were cloned into the pGL3 luciferase reporter
vector for transient transfection studies: 363/þ17-luc and mut-
CEBP-363/þ17-luc (C/EBPb binding sites at 340/-336 and 327/-
323 were mutated from GCAATTTTAAAAAGCAAT to
GCGGTTTTAAAAAGCGGT; mutated sites are underlined). The pGL3
basic vector was used as a control. Plasmid transfection experi-
ments were performed using Lipofectamine 2000 according to the
manufacturer's protocol (Invitrogen).
2.5. Small interfering RNA (siRNA)-mediated knockdown (KD)
For the siRNA KD experiment, Hmga2 siRNAs (siHmga2-1: 50-
GACCCAAAGGCAGCAAAAATT-30; siHmga2-2: 50-GAAAGCAGA-
GACCAUUGGATT-30) were synthesized and transfected into cells by
RNAiMAX according to the manufacturer's protocol (Invitrogen).
GL3 siRNA (siGL3: 50-CUUACGCUGAGUACUUCGATT-30) was used as
a control.
2.6. Immunoﬂuorescene analysis
After ﬁxing cells with either 4% paraformaldehyde or 100%
methanol, cells were incubated with primary antibodies against
GFP (ab13970; Abcam) or C/EBPb. Images were analyzed using
Lumina Vision software.
2.7. Chromatin immunoprecipitation (ChIP) and quantitative PCR
analysis
ChIP was performed as previously described [19]. Brieﬂy, 3T3-L1
cells were cross-linked with 1% formaldehyde, and crude cell ly-
sates were sonicated. ChIP was performed with anti-C/EBPb and
control rabbit IgG (Santa Cruz Biotechnology). DNA enrichment was
determined by quantitative PCR, and was normalized to input.
Primers are listed in Table 1.
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Dual luciferase reporter assays were performed according to the
manufacturer's protocol (Promega). For Pparg2 promoter analysis,
the pGL3-Pparg2 promoter reporter vector and the reference vector
pRL-SV40 were co-transfected with pcDNA3-FLAG-HMGA2 and/or
pcDNA3-C/EBPb into 293T cells using Lipofectamine 2000 (Invi-
trogen). After 24 h, cells were lysed and collected for luciferase
measurement. Fireﬂy luciferase activities were normalized to
renilla luciferase activities.
2.9. Statistic analysis
Data are presented as means ± S.D. A two-tailed Student's t-test
was applied, and p < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. HMGA2 is rapidly increased at the early phase of adipogenic
differentiation
To understand the precise function of HMGA2 during adipo-
genesis, we ﬁrst examined the time course of Hmga2 expression
during the differentiation of 3T3-L1 preadipocytes. As shown in
Fig. 1A, the Hmga2 mRNA level was rapidly elevated at 3 h after
adipogenic induction and gradually declined to basal levels within
72 h. Thereafter, Hmga2 mRNA remained at low levels until 168 h
post-differentiationwhen amature status of adipocytewas reached
as indicated by the adipocyte marker proteins PPARg and FABP4
(Fig. 1A and B). The protein level of HMGA2 exhibited a similarFig. 1. Hmga2 is transiently increased during the early stage of adipogenic differentiation. (A
harvested at indicated time points after adipogenic induction. Hmga2 expression was determ
and are presented as means ± S.D. of three samples. (B) Protein levels of Hmga2, C/EBPb,
western blot. (C) Hmga2 mRNA expression during the adipogenic differentiation of stromal v
WAT was cultured and harvested at indicated time points after adipogenic induction. (D) Hexpression pattern with its mRNA level (Fig. 1B). While the Hmga2
mRNA level peaked at 8 h after induction, the protein expression
was highest at 24 h (Fig. 1A and B).
A further investigation was performed using ex vivo differenti-
ation of SVF preadipocytes from mouse WAT, in which Hmga2
mRNA expression rapidly increased after induction (Fig. 1C).
Moreover, compared with SVF preadipocytes, the crude adipose
tissue, which mainly consists of mature adipocytes, showed an
extremely low level of Hmga2 transcript (Fig. 1D). These data
indicate that HMGA2 is transiently expressed at an early phase of
adipogenesis both in vitro and in vivo.3.2. HMGA2 promotes adipogenic differentiation
To test whether Hmga2 participates in the adipogenic program,
we introduced Hmga2 siRNAs into 3T3-L1 cells before differentia-
tion induction (Fig. 2AeC). Hmga2 KD resulted in the markedly
decreased amount of lipid-containing mature adipocytes as
revealed by oil red O staining (Fig. 2D). The same experiment was
performed using ex vivo differentiation of SVF cells from mouse
WAT (Fig. 2EeG). As shown in Fig. 2G, the frequency of mature
adipocytes was reduced by Hmga2 KD.
To further address whether HMGA2 could inﬂuence the pro-
gression of differentiation, we introduced human HMGA2 cDNA,
which shares a very high sequence similarity to mouse Hmga2, into
3T3-L1 preadipocytes (Fig. 2H). As shown in Fig. 2I, the over-
expression of HMGA2 enhanced the intracellular lipid accumula-
tion. These results strongly indicate that HMGA2 promotes the
differentiation of preadipocytes.) Hmga2 mRNA expression during adipogenic differentiation of 3T3-L1 cells. Cells were
ined by qRT-PCR using b-actin as a control. Values indicate mRNA levels relative to 0 h
Pparg, and FABP4 during adipogenic differentiation of 3T3-L1 cells were detected by
ascular fractions (SVF) from white adipocyte tissue (WAT) of C57BL/6 mouse. SVF from
mga2 mRNA expression in mouse SVF and crude adipocytes.
Fig. 2. HMGA2 is promotes adipogenesis in 3T3-L1 cells. (A) Schematic of the experiment. (B and C) siRNA-mediated knockdown of Hmga2. Reduction of Hmga2 was conﬁrmed at
mRNA (B) and protein (C) levels at 96 h after siRNA introduction. siGL3 was used as a non-targeting control. (D) Oil red O staining of siRNA-transfected 3T3-L1 cells at 8 days of
differentiation. Scale bar indicates 10 mm. (E and F) siRNAs-mediated knockdown of Hmga2. Reduction of HMGA2 was conﬁrmed at mRNA (E) and protein (F) levels at 96 h after
siRNA introduction. siGL3 was used as a non-targeting control. (G) Oil red O staining of siRNAs treated cells at eight days of differentiation. (H) Veriﬁcation of human HMGA2
expression by western blot in 3T3-L1 cells. (I) Oil red O staining of 3T3-L1 cells transfected with human HMGA2 after 5 days of differentiation. Scale bar indicates 10 mm. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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PPARg2, a master adipogenic transcription factor, is absolutely
necessary for adipogenesis. We observed that during adipogenesis,
Pparg2 expression increased after the pulsatile expression of
HMGA2 (Fig. 1B and Fig. 3A), suggesting the possible regulation of
Pparg2 gene by HMGA2. Indeed, Pparg2 expression at both mRNA
and protein levels were decreased by Hmga2 KD at 24 and 168 h
(Fig. 3BeE). In agreement with this, the expression of downstream
target genes of PPARg, such as Fabp4, Adiponectin, and Cd36, were
dramatically decreased (Fig. 3B and D). These results suggest that
HMGA2 promotes the expression of PPARg2 and its downstream
genes during adipogenesis.
3.4. HMGA2 cooperates with C/EBPb to facilitate PPARg2 expression
Activation of Pparg2 gene expression is mainly controlled by C/
EBPb, which is an early-induced transcription factor duringadipogenesis [1]. Interestingly, we observed a synchronous
expression pattern between C/EBPb and Hmga2 (Fig. 1B), raising
the possibility that these TFs work cooperatively. To test this, we
performed an immunocytochemical experiment and found that
HMGA2 and C/EBPb were co-localized in the nucleus of differen-
tiating adipocytes (Fig. 4A). We next performed ChIP assays to
evaluate the recruitment of C/EBPb at the Pparg2 gene promoter.
We observed an enrichment of C/EBPb at its known binding region
[21], which was abolished by Hmga2 KD (Fig. 4B). To gain a direct
insight into whether HMGA2 is involved in C/EBPb-mediated
expression of Pparg2, we carried out a reporter assay using a
luciferase gene under control of the Pparg2 promoter that harbors a
C/EBPb binding site (Fig. 4B & C) [21]. As displayed in Fig. 4D, either
overexpression of HMGA2 or C/EBPb signiﬁcantly increased the
reporter expression, which was further augmented by the combi-
nation of two factors. Our results strongly suggested that HMGA2
positively affected C/EBPb regulation on Pparg2 promoter activity.
Moreover, when the reporter construct bearing a mutated C/EBP
Fig. 3. Decreased expression of PPARg2 and its downstream target genes by Hmga2 knockdown. (A) 3T3-L1 cells were harvested at indicated time points after adipogenic induction.
Expression of Hmga2 and Pparg2 was determined by qRT-PCR using b-actin as a control. Values are presented as means ± S.D of three samples. (B, D) qRT-PCR analysis of mRNA
expression of Pparg2 and its target genes after Hmga2 siRNA introduction for 72 h, followed by differentiation induction of 24 h (B) and 168 h (D). b-Actin was used as a control.
Values indicate the mRNA levels relative to siGL3 and are presented as means ± S.D. of three samples. *P < 0.05. (C, E) Western blot analyses of PPARg2 and its targets after Hmga2
siRNA treatment for 72 h followed by a differentiation induction of 24 h (C) and 168 h (E). b-Actin was used as a protein loading control.
Y. Xi et al. / Biochemical and Biophysical Research Communications 472 (2016) 617e623 621site was used, HMGA2 did not enhance the reporter expression,
suggesting that the effect of HMGA2 on Pparg2 promoter activity
was mediated mostly by C/EBPb (Fig. 4D).
Collectively, our data clearly indicate that HMGA2 promotes
Pparg2 gene expression by facilitating the C/EBPb binding at the
promoter.
4. Discussion
Previous studies have demonstrated that HMGA2 is an essential
component of the adipogenic program with a possible link to hu-
man obesity [16]. In addition, Hmga2 was preferentially expressed
in embryonic and undifferentiated cells compared with maturecells [22], raising the possibility that HMGA2 might regulate the
proliferation and/or differentiation of adipogenic progenitor cells.
In the present study, we found that Hmga2 is expressed exclusively
at the very early phase of adipogenesis and promotes differentia-
tion. HMGA2 has been implicated in the regulation of cell-cycle
progression [12,15,17]. However, we did not observe a prolifera-
tive defect in Hmga2 KD preadipocytes, suggesting that the severe
lipodystrophic phenotype of Hmga2 knockout mice was mainly due
to the impaired differentiation potency of preadipocytes [14].
C/EBPb is an early adipogenic factor that increases shortly after
differentiation induction [7]. C/EBPb induces the expression of
PPARg2, which in turn activates downstream targets involved in
adipocyte functions such as triglyceride storage [6,23]. Previous
Fig. 4. HMGA2 co-localized with C/EBPb and was necessary for C/EBPb binding at the Pparg2 promoter for C/EBPb-mediated transcriptional activation of the Pparg2 gene. (A) Co-
localization analysis of HMGA2 and C/EBPb by immunoﬂuorescence. Human HMGA2 was overexpressed in 3T3-L1 cells for 72 h and immunoﬂuorescence analysis was performed,
followed by a differentiation induction for 24 h. Scale bar indicates 10 mm. (B) Analysis of C/EBPb binding at the Pparg2 promoter by ChIP. ChIP was performed using C/EBPb
antibodies after Hmga2 siRNA treatment for 72 h followed by a differentiation induction for 24 h. C/EBPb enrichment was evaluated using the primer sets against three genomic
regions as indicated. Pre-immune IgG was used as a control. Values indicate the percentage against input DNA and are presented as means ± S.D. of three samples. *P < 0.05. (C)
Schematic of luciferase reporter construct with cloned Pparg2 promoter region containing a C/EBPb binding site. The C/EBPb binding site is originally located at 340 to 323 from
transcription start site of the Pparg2 gene. Small characters indicate the mutated nucleotides of the C/EBPb-binding site. (D). Effects of exogenous HMGA2 and/or C/EBPb on
transcriptional activity of Pparg2 by luciferase reporter assay. Overexpression plasmids pcDNA3-HMGA2 and/or pcDNA3-C/EBPb were co-transfected either with 363/þ17-luc,
mut-CEBP-363/þ17-luc, or pGL3basic into 293T cells for 24 h. Bar graphs represent means ± SE (%) of luciferase activity (the activity of 363/þ17-luc without pcDNA3-HMGA2 and
pcDNA3-C/EBPb as 100%). *P < 0.05.
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Pparg gene prior to the transcriptional activation during the early
phase of adipogenesis [4,5]. We found that HMGA2 enhances C/
EBPb-mediated transcription of the Pparg2 gene. HMGA2, as an
architectural TF, changes chromatin conformation through binding
to AT-rich sequences and bending DNA, which consequently pro-
vides docking sites for other TFs [9,22,24,25]. Therefore, HMGA2
may facilitate the DNA binding of C/EBPb by controlling the local
chromatin structure at the Pparg2 promoter. Moreover, recent
high-throughput sequencing approaches have revealed that the
chromatin structure is dramatically remodeled at a genome-wide
level during adipogenesis [26]. Thus, an intriguing possibility is
that HMGA2 might work at many gene loci to build an epigenetic
foundation that allows the access of adipogenic TFs.
A recent study showed a signiﬁcant association of obesity with
an increase in the expression of HMGA2 [16]. Moreover, higher
HMGA2 expression in adipose tissue in patients with type 2 dia-
betes was detected [16]. Interestingly, high expression of HMGA2
was reported to be induced by a high-fat diet, which was associated
with the acquisition of obesity in mice [15]. Here, we found that
HMGA2 plays a key role in the initiation of the adipogenic program,
which may be a critical event that links nutrition to obesity and
related metabolic diseases.
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